top of page

blueprint for precision medicine in canada

Canada is at a pivotal moment in the evolution of precision medicine. While advances in genomic testing, data analytics, and targeted therapies have opened new frontiers in care, implementation across the country remains fragmented. Disparities in access, infrastructure gaps, and a lack of coordinated strategy have slowed the realization of precision medicine’s full potential for Canadians.

 

the cancer collaborative is launching a national precision medicine think tank- building a blueprint for precision medicine in Canada to catalyze a pan-Canadian strategy that is equitable, actionable, and grounded in collaboration. Join leaders from across clinical care, research, policy, advocacy, and industry as we co-create a shared strategy and actionable roadmap to drive precision medicine forward—together.

​

It’s a working forum to define where we are, where we need to go, and how we get there. And it’s the launchpad for the precision medicine co.laboratory—a multistakeholder hub designed to break silos, drive collaboration, and turn strategy into real-world impact.

​

​

What You’ll Help Build

  • A Pan-Canadian Precision Medicine Strategy grounded in collaboration, equity, and action

  • A national stakeholder map to reduce duplication and align efforts

  • A precision medicine roadmap with tangible milestones and timelines

​

​

Who Should Attend

We’re bringing together a curated group of experts, leaders, and changemakers including:

  • Oncologists, pathologists, and genomic specialists

  • Patient advocates and lived experience experts

  • HTA and policy leaders (e.g., CDA-AMC, INESSS)

  • Provincial and national health planners

  • Biopharma and diagnostic industry innovators

  • Researchers, data experts, and digital health leaders

  • Health system strategists and implementation specialists

 

If you care about shaping the future of cancer care and innovation in Canada—you belong in this room.

Yellow Blue Bold Illustrative Marathon Event Landscape Banner (1).png

register to save your seat at the precision medicine think tank

Product
  • Who should attend?
    This event is open to anyone involved in shaping the future of precision medicine in Canada, including: Clinicians (oncologists, pathologists, genomic experts) Patient advocates and lived experience experts HTA and policy leaders (e.g., CDA-AMC, INESSS) Health system planners and strategists Biopharma, diagnostics, and biotech innovators Researchers, data scientists, and digital health leaders
  • What are the event dates and format?
    the think tank will take place virtually on October 28–29, 2025.a link will be sent closer to the event date.
  • Is there a cost to attend?
    To ensure broad and meaningful participation, we’ve tailored our fee structure: Free for patients, caregivers, and patient advocates Nominal fee for researchers, clinicians, policymakers, and health system leaders Registration fee applies for industry participants (to maintain a balanced and collaborative dialogue) Fees help support event facilitation and post-event deliverables. If cost is a barrier for participation, please reach out—we’re committed to inclusivity.
  • What will I get out of participating?
    You’ll help co-create: A pan-Canadian strategy for precision medicine A national stakeholder and ecosystem map A roadmap with clear milestones and priorities The founding structure for a multistakeholder Precision Medicine Co.Laboratory You’ll also have the opportunity to continue participating in post-event working groups and implementation activities.
  • Will the sessions be recorded?
    To ensure open dialogue and active collaboration, most sessions will be live only. A post-event summary report and synthesized outputs will be shared with participants.
  • How do I stay involved after the event?
    Participants will be invited to join ongoing working groups and the development of the precision medicine co.laboratory to support strategy execution and stakeholder alignment.
  • How can I get more information?
    For more information please contact sabrina hanna at sabrina@cancercolab.ca
bottom of page